Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Telmisartan and Lacidipine Alone and in Combination
NCT02203500Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Oct 1998
- Primary completion
- Jan 1999
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of telmisartan and lacidipine in hypertension (HTN) (3 arms), sponsored by Boehringer Ingelheim. Primary endpoints: Number of subjects with clinically significant changes in vital signs, Number of subjects with abnormal changes in laboratory parameters and 9 more. Started Oct 1998; status: completed.
02
Drugs
telmisartanlacidipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02203500.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02203500.